Cargando…

Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans

The aim of this study is to define, for the first time, human methylone and HMMC plasma pharmacokinetics following controlled administration of 50–200 mg methylone to 12 male volunteers. A new LC-MS/MS method was validated to quantify methylone, MDMA, and their metabolites in plasma. The study was a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poyatos, Lourdes, Lo Faro, Alfredo Fabrizio, Berardinelli, Diletta, Sprega, Giorgia, Malaca, Sara, Pichini, Simona, Huestis, Marilyn A., Papaseit, Esther, Pérez-Mañá, Clara, Busardò, Francesco Paolo, Farré, Magí
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736016/ https://www.ncbi.nlm.nih.gov/pubmed/36498963 http://dx.doi.org/10.3390/ijms232314636

Ejemplares similares

Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans
por: Di Giorgi, Alessandro, et al.
Publicado: (2023)

Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH
por: Sprega, Giorgia, et al.
Publicado: (2023)

Pharmacological effects of methylone and MDMA in humans
por: Poyatos, Lourdes, et al.
Publicado: (2023)

A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure
por: Poyatos, Lourdes, et al.
Publicado: (2021)

Toxicology and Analysis of Psychoactive Tryptamines
por: Malaca, Sara, et al.
Publicado: (2020)

Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS
por: La Maida, Nunzia, et al.
Publicado: (2020)

Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study
por: Martínez, Lucia, et al.
Publicado: (2021)

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
por: Busardò, Francesco Paolo, et al.
Publicado: (2021)

Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users
por: Maida, Nunzia La, et al.
Publicado: (2021)

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
por: Pérez-Acevedo, Ana Pilar, et al.
Publicado: (2020)

New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic
por: Lo Faro, Alfredo Fabrizio, et al.
Publicado: (2023)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2020)

GC–MS/MS Determination of Synthetic Cathinones: 4-chloromethcathinone, N-ethyl Pentedrone, and N-ethyl Hexedrone in Oral Fluid and Sweat of Consumers under Controlled Administration: Pilot Study
por: Nuñez-Montero, Melani, et al.
Publicado: (2023)

Interaction of Energy Drinks with Prescription Medication and Drugs of Abuse
por: Hladun, Olga, et al.
Publicado: (2021)

Medicinal Cannabis and Synthetic Cannabinoid Use
por: Pichini, Simona, et al.
Publicado: (2020)

Methylone and Monoamine Transporters: Correlation with Toxicity
por: Sogawa, Chiharu, et al.
Publicado: (2011)

Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances
por: Di Trana, Annagiulia, et al.
Publicado: (2022)

Human Hepatocyte 4-Acetoxy-N,N-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry
por: Malaca, Sara, et al.
Publicado: (2022)

Pharmacokinetic, Ambulatory, and Hyperthermic Effects of 3,4-Methylenedioxy-N-Methylcathinone (Methylone) in Rats
por: Štefková, Kristýna, et al.
Publicado: (2017)

Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs
por: Busardò, Francesco Paolo, et al.
Publicado: (2018)

Cannabidiol, ∆(9)-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients
por: Pigliasco, Federica, et al.
Publicado: (2022)

Drug Interactions With New Synthetic Opioids
por: Pérez-Mañá, Clara, et al.
Publicado: (2018)

MDMA Impairs Response to Water Intake in Healthy Volunteers
por: Baggott, Matthew J., et al.
Publicado: (2016)

Abuse Potential of Cathinones in Humans: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2022)

New Psychoactive Substances Consumption in Opioid-Use Disorder Patients
por: Alías-Ferri, Maria, et al.
Publicado: (2022)

Synthetic cannabinoids use in a sample of opioid-use disorder patients
por: Alías-Ferri, María, et al.
Publicado: (2022)

MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?
por: de la Torre, Rafael, et al.
Publicado: (2012)

UHPLC-HRMS and GC-MS Screening of a Selection of Synthetic Cannabinoids and Metabolites in Urine of Consumers
por: Pellegrini, Manuela, et al.
Publicado: (2020)

Molecular Insights on New Psychoactive Substances (NPSs)
por: Busardò, Francesco Paolo, et al.
Publicado: (2022)

Methylone, a rapid acting entactogen with robust anxiolytic and antidepressant-like activity
por: Warner-Schmidt, Jennifer, et al.
Publicado: (2023)

MDMA-Induced Dissociative State not Mediated by the 5-HT(2A) Receptor
por: Puxty, Drew J., et al.
Publicado: (2017)

Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)
por: Pardo-Lozano, Ricardo, et al.
Publicado: (2012)

The Influence of Genetic and Environmental Factors among MDMA Users in Cognitive Performance
por: Cuyàs, Elisabet, et al.
Publicado: (2011)

UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations
por: Malaca, Sara, et al.
Publicado: (2021)

Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence
por: Mas, Marta, et al.
Publicado: (2022)

Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis
por: Torres-Moreno, Mari Carmen, et al.
Publicado: (2018)

Enantioselectivity of Pentedrone and Methylone on Metabolic Profiling in 2D and 3D Human Hepatocyte-like Cells
por: Silva, Bárbara, et al.
Publicado: (2022)

European Drug Users at Risk from Illicit Fentanyls Mix
por: Pichini, Simona, et al.
Publicado: (2017)

Acute Pharmacological Effects of 2C-B in Humans: An Observational Study
por: Papaseit, Esther, et al.
Publicado: (2018)

Editorial: The Challenge Posed by New Synthetic Opioids: Pharmacology and Toxicology
por: Pichini, Simona, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5gukn1s1l8r032dpleqspgqmd8